Treatment of intertrigo with zinc oxide in ketoconazolecream with or without substitution of hydrocortisone-acetaat

Phase 3

Completed

• Conditions: intertigo; moist lesion; 10040792

• Registration Number: NL-OMON30558
• Lead Sponsor: Medisch Centrum Leeuwarden

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 65

Inclusion Criteria

- Two-sided intertrigo in the folds of the groin, axillairy or submammary
- The intertrigo may not been treated yet beside treatment with zincoxide.
- There has to be a control after 5-7 days.

Exclusion Criteria

- Patients may not have a hypersensibility for one of the componements of the different creams
- Patients may not have a (skin)disease that might can influence the aspect or the threatment for this study neither have a contraindication to start the treatment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Reduce in percentage of the area of the intertigo compared to the other side<br /><br>that has not been treated with the hydrocortisone-acetaat.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Local complainments as pruritis, pain, redness and scaly. Also the results of<br /><br>the cultured samples are evaluate whereby we will look at the percentage of<br /><br>positive results and the reaction or the different treatments.</p><br>